Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Other1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT05025488Phase 1Active Not Recruiting
Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm
Essential ThrombocythemiaMPNMyelofibrosis
StudychairStart date: 2023-04-04

Research Network

Collaboration Network

11 collaborators·11 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Icahn School of Medicine at Mount Sinai

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Nina Bhardwaj, MD, PhD

Icahn School of Medicine at Mount Sinai

Moderately Similar
8 trials

Shared therapeutic areas:

Thrombocythemia, EssentialMPNPrimary Myelofibrosis

Worked with same sponsors:

Marina Kremyanskaya
Collaborated on 1 trial
Similarity Score34%

Marina Kremyanskaya, MD, PhD

Icahn School of Medicine at Mount Sinai

Moderately Similar
3 trials

Shared therapeutic areas:

Primary MyelofibrosisThrombocythemia, EssentialMPN

Worked with same sponsors:

Marina Kremyanskaya
Collaborated on 1 trial
Similarity Score34%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Primary MyelofibrosisThrombocythemia, Essential
Similarity Score20%

Rami Komrokji, MD

H. Lee Moffitt Cancer Center and Research Institute

Related
5 trials

Shared therapeutic areas:

Thrombocythemia, EssentialPrimary Myelofibrosis
Similarity Score20%

John Mascarenhas, MD

Icahn School of Medicine at Mount Sinai

Related
16 trials

Shared therapeutic areas:

Primary MyelofibrosisThrombocythemia, Essential
Similarity Score20%

Ronald Hoffman, MD

Icahn School of Medicine at Mount Sinai

Related
10 trials

Shared therapeutic areas:

Primary MyelofibrosisThrombocythemia, Essential
Similarity Score20%

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Thrombocythemia, EssentialPrimary Myelofibrosis
Similarity Score20%

Brenda Sandmaier

Fred Hutch/University of Washington Cancer Consortium

Related
7 trials

Shared therapeutic areas:

Thrombocythemia, EssentialPrimary Myelofibrosis
Similarity Score20%

Martha Wadleigh, MD

Dana-Farber Cancer Institute

Related
3 trials

Shared therapeutic areas:

Primary MyelofibrosisThrombocythemia, Essential
Similarity Score20%

Josef T Prchal, MD

University of Utah

Related
6 trials

Shared therapeutic areas:

Primary MyelofibrosisThrombocythemia, Essential
Similarity Score20%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05025488Phase 1StudyChair

Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm

Essential ThrombocythemiaMPNMyelofibrosis
Active Not Recruiting

All 1 trials loaded